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Abstract
This study examines the roles of age, period, and cohort in influenza mortality
trends over the years 1959–2016 in the United States. First, we use Serfling models
based on Lexis surfaces to highlight influenza mortality patterns as well as to
identify lingering effects of early-life exposure to specific influenza virus subtypes
(e.g., H1N1, H3N2). Second, we use age-period-cohort (APC) methods to explore
APC linear trends and identify changes in the slope of these trends (contrasts). Our
analyses reveal a series of breakpoints where the magnitude and direction of birth
cohort trends significantly change, mostly corresponding to years in which impor-
tant antigenic drifts or shifts took place (i.e., 1947, 1957, 1968, and 1978). Whereas
child, youth, and adult influenza mortality appear to be influenced by a combination
of cohort- and period-specific factors, reflecting the interaction between the anti-
genic experience of the population and the evolution of the influenza virus itself,
mortality patterns of the elderly appear to be molded by broader cohort factors. The
latter would reflect the processes of physiological capital improvement in
successive birth cohorts through secular changes in early-life conditions. Antigenic
imprinting, cohort morbidity phenotype, and other mechanisms that can generate
the observed cohort effects, including the baby boom, are discussed.
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Introduction
At the beginning of the twentieth century, pneumonia and influenza (P&I) were the
leading causes of death in the United States (Deaton 2015), and today, they remain the
most important causes of death among infectious diseases (Armstrong et al. 1999). The
Spanish flu (1918–1920), also known as the “mother of all pandemics” (Taubenberger
and Morens 2006), caused more deaths than World War I and killed more people in 24
weeks than AIDS did over a span of 24 years (Barry 2005). The following three
influenza pandemics (1957, 1968, and 2009) and the appearance of new subtypes, such
as the highly pathogenic avian H5N1 and H7N9 influenza viruses (Haque et al. 2007),
demonstrate that influenza remains a significant threat to public health. Population
aging makes it likely that casualties will increase (Simonsen et al. 2011), given that
about 90 % of all influenza deaths occur among people aged 65 and over (Thompson
et al. 2003).
As is true for most infectious diseases, mortality from influenza diminished appre-
ciably during the twentieth century (Armstrong et al. 1999). However, there is still
much uncertainty regarding the mechanisms responsible for this reduction. The em-
phasis has been on monitoring disease and mortality from specific strains from year to
year, with indicators of virulence, basic reproductive number (the number of people
infected by one index case), or attack rates (the percentage of people infected) broken
down by geographic areas and broadly defined age groups (Reichert et al. 2004;
Thompson et al. 2010; Thompson et al. 2003). The generalized nature of these
investigations has fostered interpretations of change over time almost exclusively in
terms of secular or period change, modulated by biological age, with few alternative
explanations of time trends. More recently, some investigators have focused on age-
specific mortality from influenza during pandemics (Lemaitre et al. 2012; Nguyen and
Noymer 2013), while others have analyzed the consequences of early-life exposure to
pandemic influenza on health and mortality in general (Almond 2006; Kelly 2009;
Mazumder et al. 2010) or on mortality during subsequent influenza pandemics
(Gagnon et al. 2013; Hallman 2015; Hallman and Gagnon 2014; Ma et al. 2011;
Oeppen and Wilson 2006; Viboud et al. 2010). To our knowledge, only a few studies
(see, e.g., Azambuja 2009, 2015; Cohen et al. 2010) have undertaken an analysis of
influenza mortality variation over time in an age-period-cohort (APC) framework.
In most previous analyses, information on age was analyzed using five-year (or
larger) age groups, allowing for broad distinctions in mortality patterns among infants,
children, adolescents, adults, and seniors, but affording few chances to identify cohort
effects defined on a yearly basis, as pertaining to cohorts born during a pandemic year.
There is also nonnegligible heterogeneity within broadly defined age categories,
especially when referring to individuals in a terminal age category as broad as 65+
years. Some studies have shown an important change in influenza mortality risk after
age 60, with an 11-fold higher risk for a senior older than 80 compared with persons
65–69 (Simonsen et al. 2005, 2011; Thompson et al. 2009).
The present study examines the roles of age, period, and cohort factors as drivers of
influenza mortality change over the years 1959–2016 in the United States. It also
addresses the effect of early-life exposure to the different influenza A virus (IAV)
subtypes that have circulated over the past decades on later-life mortality in the United
States for single-year ages, periods, and cohorts, focusing on both seasonal epidemic
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and pandemic periods. To this end, we first estimated influenza mortality from death
records by single years of age in the United States from 1959 to 2016 using Serfling
models based on mortality data (Serfling 1963). Second, we used Surveillance-Serfling
models (Thompson et al. 2009) accounting for influenza-like illness incidence between
1997 and 2016 to improve parametrization of the Serfling model and to evaluate the
effect of influenza virus subtype on mortality by age. Then we constructed Lexis
surfaces from influenza death rates and applied detrended APC models (Carstensen
2007; Clayton and Schifflers 1987; Holford 1991) and the intrinsic estimator model (Fu
2000; Yang et al. 2004) to explore period and cohort effects on mortality variation. We
also estimated contrasts, proposed by Tarone and Chu (1996), to identify statistically
significant changes in mortality risk along birth cohort trends. We interpret our results
mainly in light of the antigenic imprinting hypothesis (Davenport et al. 1953; Ma et al.
2011) and the cohort morbidity phenotype hypothesis (Finch and Crimmins 2004),
described in the next section.
Age-Period-Cohort Effects on Influenza Mortality
Susceptibility to infection and mortality from influenza chiefly depends on virus-host
interaction factors and on the evolution of the virus itself (Thompson et al. 2003).
Because the immune response generated against a given strain of the IAV is not fully
cross-protective, the virus can evade the host’s immunity from one season to the next
by accumulating mutations that change its antigenicity. This process—antigenic drift—
is differentiated from the appearance of a novel IAV by reassortment of the HA and NA
surface proteins of IAV—antigenic shift—which can lead to pandemics (Nelson and
Holmes 2007).
Whereas typical IAV seasonal outbreaks most seriously affect the elderly
(Thompson et al. 2010), epidemiological analyses of influenza pandemics have
revealed a shift of mortality toward younger ages, as was the case during the 1918,
1968, and 2009 pandemics (Nguyen and Noymer 2013; Oeppen and Wilson 2006;
Simonsen et al. 1998). During these outbreaks, older individuals often benefited
from immunity acquired from previous exposures to virus strains similar to the
current pandemic strain, whereas younger adults and children were at higher risk
because of a lack of cross-protection from previous infections by similar IAVs. Risk
can also be compounded in younger individuals, whose strong immune response to
the virus can quickly turn overreactive and dysregulated, leading to immunopathol-
ogy and organ damage (Kobasa et al. 2007; Loo and Gale 2007; Shanks and
Brundage 2012).
The antigenic imprinting hypothesis additionally postulates that mortality from
influenza depends not only on the virulence of the circulating strain but also on
the strain to which a specific cohort was primed (Davenport et al. 1953; Ma
et al. 2011; Rajendran et al. 2017). This original strain would indeed keep its
senior position in the immune repertoire over successive episodes of infection,
with each novel strain taking a more junior position (Henry et al. 2018; Miller
et al. 2013). Based on studies showing the variable efficacy of repeated annual
influenza vaccination (Smith et al. 1999), protection is expected when the
original strain is similar to the circulating strain; however, if the two are very
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dissimilar, susceptibility to severe outcome may increase (Cobey and Hensley
2017). According to this hypothesis, infection in the first years of life with a
H3N8 virus, as was presumably the case for those born during the 1890 Russian
IAV pandemic (Worobey et al. 2014), increased the risk of death upon encounter
with the doubly heterosubtypic H1N1 virus that was responsible for the Spanish
flu pandemic in 1918 (Gagnon et al. 2013; Hallman and Gagnon 2014; Shanks
and Brundage 2012). Corroborating this, 50 years later during the 1968 H3N2
Hong Kong flu pandemic, the largest excess mortality was for those aged 50 or a
little older (Gagnon et al. 2015). Similarly, a peak in excess mortality during the
2009 H1N1 pandemic was observed at age 52—that is, for those born in 1957—
at the time of the H2N2 Asian flu pandemic (Gagnon et al. 2018a).
Hence, whereas mortality at all ages during a given year should reflect the virulence
of the circulating strain that year, mortality levels of a specific cohort are expected to
reflect the antigenic distance between this strain and the first strain this cohort encoun-
tered in early life. The priming of specific cohorts to specific viral strains is thus
expected to produce punctual cohort-specific influences, independently of period or
cohort trends—that is, longer-term ascending or descending mortality trends that persist
over time.
Patterns of influenza mortality may also be interpreted in the light of broader
theoretical perspectives, such as Finch and Crimmins’ cohort morbidity phenotype
hypothesis (2004), which attributes the vast reductions in later-life mortality from
chronic conditions over the last 200 years to the secular reduction in infections
during early life. Together, improvements in nutrition and the declining incidence of
infectious diseases have been almost continuous since the Industrial Revolution
(Floud et al. 2011). Both are believed to have played a salient role in boosting
physiological capital, an initial health advantage resulting from improved condi-
tions during infancy and early childhood, leading to large increases in life expec-
tancy (Fogel and Costa 1997; Meslé and Vallin 2000).
The cohort morbidity phenotype hypothesis specifically addresses secular
changes in mortality from chronic or nontransmissible diseases in old age. Yet,
much research has also documented strong comorbidities between chronic dis-
eases and influenza-related mortality for people over age 65 (Plans-Rubió 2007;
Reichert et al. 2004; Simonsen et al. 2005). The cohort morbidity perspective
provides a rationale to address past reductions in mortality from influenza from a
cohort perspective—and more generally from an APC perspective—and not only
as the result of secular (period) changes. In other words, improved survival from
IAV infections in successive cohorts of elderly could have resulted not only from
enhanced responses to infection and to medical treatments but also from delayed
onset of comorbid conditions involving influenza and chronic diseases. In this
respect, other cohort processes may also shape influenza mortality via these
comorbidities or its relationship with mortality in general. For instance, increases
in all-cause mortality have also been documented for the baby boomer generation
in recent years (Canudas-Romo and Guillot 2015; Rau et al. 2013), and it is
possible that what drives these cohort processes also partly drives influenza
mortality. Thus, our study also briefly addresses the baby boom as a possible
contributor to APC trends in influenza mortality.
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Data and Methods
Data
Aggregate U.S. death counts by month, single years of age, cause, and sex between
January 1959 and December 2016 were obtained from the National Center for Health
Statistics (2018). These data cover four successive revisions of the International
Statistical Classification of Diseases (from ICD-7 to ICD-10) to classify the deaths.
Concordance tables bridged the 7th, 8th, and 9th to the 10th ICD revisions to ensure
consistency of definitions for disease categories under study and their comparability
over time (Anderson et al. 2001; Klebba and Dolman 1975; Klebba and Scott 1980).
Annual counts of population at risk from 1959 to 2016 by single years of age were
taken from the Human Mortality Database (2019); monthly counts were estimated
through interpolation. Monthly indicators of influenza-like illness (ILI) and percentages
of respiratory specimens testing positive for influenza between 1997 and 2016 were
estimated from weekly indicators registered in the Centers for Disease Control (CDC)
FluView Interactive database (2018). All these data are openly available in the refer-
enced websites. Annual percentages of respiratory specimens testing positive for
influenza between 1976 and 1996 were obtained from Thompson et al. (2003).
Influenza Mortality
Measuring and estimating cause-specific mortality is challenging. Mortality from influ-
enza is no exception (Thompson et al. 2009). On one hand, death records do not contain
information from laboratory tests to confirm influenza as the underlying cause of death.
Therefore, many deaths recorded as “deaths from influenza” may, in fact, result from
morbid events initiated by a disease other than influenza. On the other hand, an influenza
infection could trigger a wide spectrum of secondary complications, such as bacterial
infections, heart disease, or kidney and diabetes complications, among others (Simonsen
et al. 2011), and many deaths primarily due to influenza infections may be wrongly
attributed to another cause. Previous analyses of U.S. death certificates confirm that
reports of influenza as a standalone cause of death are not to be trusted and should be
regrouped first with other causes of death prior its estimation and analysis (Noymer and
Nguyen 2013). Given that our purpose is to specifically account for APC effects on
influenza mortality, and not to precisely estimate general influenza mortality levels, we
estimated the Serfling models based on the restricted P&I cause-of-death category.
The Serfling Regression Model
Serfling models estimate a mortality baseline by fitting death counts of the summer
season, during which influenza virus does not circulate widely, while taking into
account seasonal and secular mortality trends (Serfling 1963; Thompson et al. 2009).
Influenza-related mortality is then estimated for each month as the difference between
the observed P&I death counts and the estimated baseline (see Fig. 1). Note that the
amplitude of the baseline (and thus the estimated number of deaths) depends on the
months chosen to define the summer period. According to our estimates, the best fit
The Surveillance-Serfling Regression Model
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Fig. 1 Monthly observed P&I death counts and baseline mortality (without influenza activity) predicted by the
Serfling model at age 80, 1959–2016
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was obtained when using a summer period from June to September (details of the
Serfling model and the sensitivity tests of alternative summer period definitions are
provided in the online appendix).
One important advantage of the Serfling model is that it requires only death counts
and populations at risk by month and age. In the present case, it permits the estimation
of influenza mortality over a long period (from 1959 to 2016). However, because it
relies strongly on seasonal variations, this model may capture unrelated mortality that
follows a similar seasonal pattern leading to incoherent estimates, such as a negative
number of influenza deaths (Nguyen and Noymer 2013)—hence the interest of the
Surveillance-Serfling model described next.
Besides the three components of the Serfling regression model (time trend, seasonality,
and population at risk), the Surveillance-Serfling model can also take into account
influenza morbidity indicators—such as ILI and other viral surveillance data—which
may considerably improve the accuracy of the estimates (Lemaitre et al. 2012;
Simonsen et al. 2011; Thompson et al. 2003, 2009). The Surveillance-Serfling model
has the further advantage of fitting data from all seasons and not exclusively from the
summer seasons; it thus includes more observation points (i.e., throughout the year),
which improves estimates for the single-year age data used in this study. We fitted this
model for the P&I underlying causes of mortality in the United States from 1997 to
2016—that is, for the periods during which measures of influenza circulation and
mortality are both available on a monthly basis. We tested several models accounting
for ILI incidence (CDC 2018), its combination with subtype circulation (ILI
decomposed by subtype according to the proportion of positive tests for H1N1,
H2N2, and so on), and including a one-month lag term tracking influenza ILI incidence
and subtype circulation the month preceding the index month. We selected the best fit
for each age based on AIC (Burnham and Anderson 2002). A detailed description of
the full model equation, the fitting procedure, and the chosen model parameterization
by age are provided in the online appendix.
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To capture influenza mortality, we first fitted the model to deaths recorded in the P&I
categories to obtain a predicted mortality count. Then we set the influenza activity terms
(i.e., flug,t and flug,t − 1 in Eq. (S2)) to 0 to obtain a mortality baseline without influenza
activity. The difference between predicted mortality and the baseline reflects mortality
caused by influenza. For example, Fig. 2 shows the number of deaths recorded within the
P&I category at age 80 between October 1997 and December 2016 (gray line), the number
of deaths predicted by the Surveillance-Serfling model given the influenza incidence
(dotted line), and the mortality baseline with the influenza terms set to 0 (black line). The
distance between the black and the dotted lines is defined as influenza-related mortality.
Lexis Surfaces
We estimated annual mortality rates over 101 single years of age (ages 0 to 100) and 57
epidemic years (from 1959–1960 through 2015–2016), comprising roughly 5,700 data
points. The construction of Lexis surfaces (Vaupel et al. 1998) is done by binding
together mortality rates estimated by the Serfling models. To identify differences in
mortality levels, a color is assigned to each data point, with the lightest color
representing the minimum mortality rate and the darkest representing the maximum.
Yearly mortality data were aggregated in our Lexis surfaces by epidemic seasons rather
than calendar years—that is, from October 1 to May 31.
Age-Period-Cohort Analyses
Besides quantifying the influences of each temporal component, statistical APC anal-
yses avoid the subjectivity that may come from visual inspection of Lexis surfaces.
Given perfect linear dependence (age = period – cohort), it is impossible, however, to
estimate a unique solution describing long-term APC trends without the imposition of
additional constraints. Acknowledging this well-known identification problem, we
propose two complementary approaches that provide tentative yet heuristic insights
on period and cohort trends over sizable stretches of historical time.
More precisely, we first evaluated period and cohort effects according to two
opposite scenarios: one in which all the linear trend in mortality change is attributed
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Fig. 2 Observed and predicted influenza death counts at age 80, 1997–2016. Between 1998 and 2002,
estimates for May–September are not included because there are no influenza circulation data for these
periods.
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to period influences (i.e., the cohort effects slope is constrained to 0), and another in
which this trend is solely attributed to cohort influences (i.e., the period effects slope is
constrained to 0), respectively denoted as the APCd and ACPd scenarios.
Second, we used the intrinsic estimator (IE) method, which finds a solution of the
partition of the linear trend between age, period, and cohort by using a constraint that
minimizes the APC variance parameter (Fu 2016; Land et al. 2016; Xu and Powers
2016). Given that the constraint is not explicitly chosen by the user, it may be seen as
less subjective than other constraints (Yang et al. 2004). Yet, the estimates may vary
widely according to the constraints, regardless of whether it is chosen by the user,
making the choice of any method ultimately arbitrary.
If there is no unique, statistically optimal solution to partitioning the long-term linear
trends in APC models, changes in the slope of these trends are, on the other hand,
unambiguously identifiable. These changes provide important information about in-
creases or decreases in mortality risks. For this analysis, we use the contrast approach
(Tarone and Chu 1996) to identify the breakpoints or “rupture points” where the trend
of the cohort effects significantly changes in direction and to quantify these changes
(contrasts). For this, we measured the difference between the slopes of two disjoint
blocks composed of several consecutive cohorts and assessed their statistical signifi-
cance according to two alternative approaches. First, we quantified the difference
between the slopes formed by the first and last cohorts of each block of cohorts.
Alternatively, we compared the sum of all slopes formed by any pair of cohorts
contained within each block.
Finally, to reduce the influence of stochastic variation on the APC model
estimates, we aggregated data on a two-year basis. To avoid undue influences of
seasonal infant and young child mortality that could be unrelated to influenza,
such as from the respiratory syncytial virus (Simonsen et al. 2011), we also
excluded ages 0–4 from the APC models. See the online appendix for a broader
discussion about the use of APC methods, details of the models, and sensitivity
analyses. The scripts for the Serfling estimates and the APC analyses are available
at https://osf.io/dv9pg/.
Results
Influenza Mortality
We describe the dynamics of influenza mortality over time by first plotting the
monthly influenza mortality counts estimated from the Serfling model over all
available calendar months (Fig. 3, panel a). In agreement with previous research,
these estimates show substantial mortality variation by period that is related to
the dominant virus subtype prevailing during each epidemic season (Reichert
et al. 2004; Simonsen et al. 1997; Thompson et al. 2010). For instance, there are
noticeable peaks in mortality for the epidemic seasons 1967–1968 and 1999–
2000, dominated by the H2N2 and H3N2 influenza subtypes, respectively. By
contrast, important mortality dips are apparent for the seasons 1976–1977, 1978–
1979, and 2009–2010, respectively dominated by the B, H1N1, and pH1N1
strains. Yet, Fig. 3a shows no clear overall mortality trend over time.
Second, we plot in Fig. 3, panel b, the standardized influenza mortality counts using
the July 2015 U.S. total population size and age structure as the standard population (so
that results for each year are adjusted to 2015). As shown in the figure, once changes in
the size and the age structure of the population are neutralized, a downward trend of
influenza mortality appears. For instance, had the 1967 U.S. population shared the size
and age structure of the 2015 U.S. population, the number of deaths due to influenza
during the whole epidemic season would have been more than three times higher
(39,973 vs. 12,463), primarily because older age groups experiencing the highest risk
of influenza mortality would have accounted for a larger share of the population.
Table 1 indicates that influenza seasons dominated by the H2N2 subtype (which
circulated in the earliest periods covered in this study and disappeared in 1968) were
the deadliest, at least based on the U.S. population of 2015 as the standard. Compared
with seasons in which the seasonal H1N1 was the dominant subtype, mortality was 2.2
Fig. 3 Serfling estimates of monthly influenza death counts (panel a) and of influenza death counts using the
total U.S. population in 2015 as the standard population (panel b)
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times higher during seasons dominated by the H2N2 subtype, 1.5 times higher for those
dominated by H3N2, and 38 % lower in the seasons when the pH1N1 subtype,
introduced during the 2009 pandemic, was dominant. If overall mortality was lower
during that pandemic (Lemaitre et al. 2012; Nguyen and Noymer 2013; Simonsen et al.
2011), it is mostly due to an overall shift in increased susceptibility from older to
younger ages. Young and middle-aged adults aged up to ages 50–60 indeed had
increased risks of death during the 2009 outbreak relative to usual influenza seasons,
whereas the opposite was true for the elderly (Gagnon et al. 2018a). Contrary to what
may be observed during pandemics, as in 2009, influenza mortality was, as expected,
higher during normal influenza seasons for the very young or the very old (see
upcoming Fig. 4).
Lexis Surfaces
Figure 4, panels a and b show Lexis surfaces of influenza mortality estimated with the
Serfling and Surveillance-Serfling models. The estimated mortality levels and patterns
from both models are highly consistent. Along the age dimension, the surfaces uncover
high mortality for the newborn, very low mortality for children and young adults, and a
considerable increase in the risk of death after age 50 or 60, as one would expect for
this disease.
Table 1 Influenza-associated mortality by dominant viral strain using the size and the age distribution of the
total U.S. population in 2015 as the standard population, influenza seasons 1959–2016
Dominant Straina
Average Number
of Deaths per
Epidemic Seasonc
Standardized Average
Number of Deaths per
Epidemic Seasond
Relative Risk
of Deaths
(ref. = H1N1)d
B 8,661 17,504 1.10
H1N1 9,075 15,967 Ref.
pH1N1 9,274 9,946 0.62
H2N2 11,311 34,947 2.19
H3N2 13,024 23,844 1.49
No Dominant Strainb 11,056 15,836 0.99
a The dominant strain for a specific season was defined as the strain that cumulated at least 50 % of all isolates
identified during that season. H2N2 was imputed as the dominant subtype between 1959 and 1975, when no
data about subtype tests are available.
b Influenza seasons for which no subtype reached 50 % of all isolates. Four seasons show no dominant
subtype: 1988–1989, 2002–2003, 2006–2007, and 2010–2011.
c Influenza mortality was estimated from the Serfling model applied to P&I mortality data.
e Influenza mortality standardized using the total U.S. population in 2015.
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The surfaces also show high variations of mortality by period, with important
mortality surges at all ages during the 1968–1969 pandemic, as well as during the
flu seasons of 1972–1973 (Chin et al. 1974), 1999–2000 (CDC 2000), and 2003–
2004 (Meadows 2004), all of which resulted from significant drift events of the
H3N2 strain (see periods identified by arrows a, b, d, and e at the top of both panels
in Fig. 4). Although the 2009 pandemic and the 2013–2014 season were not
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Fig. 4 Lexis surfaces of influenza mortality rates estimated by the Serfling model, 1959–2016 (panel a) and
the Surveillance-Serfling model, 1997–2016 (panel b). The vertical arrows a, b, d, and e indicate periods of
severe H3N2 epidemics. Arrow c marks the reappearance of H1N1 (1977–1978); arrows f and g indicate
periods dominated by pH1N1. The solid and dashed black diagonal lines mark the 1947 and 1968 birth
cohorts, respectively. The surface covered by the dashed square in panel a is shown in a three-dimensional
perspective in Fig. 5
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particularly lethal, they show a mortality shift from older to younger ages (see
periods identified with arrows f and g), especially in 2009. As discussed earlier,
mortality levels are highly dependent on the predominant virus subtype circulating
during each epidemic season. In this sense, the 1960s and 1970s, the second half of
the 1990s, as well as the first half of the 2000s are considered as extended periods
with high influenza mortality, coinciding with the circulation of the H2N2 and
H3N2 subtypes. Conversely, lower mortality is observed after the reappearance of
the H1N1 at the end of the 1970s (see period identified with arrow c), especially
during the first halves of the 1980s and 1990s, and during the second half of the
2000s, which were dominated by this milder seasonal subtype.
Diagonal patterns in Fig. 4 also suggest the presence of cohort effects. These
are immediately perceptible from the 1960s to the beginning of the 1980s, and
again from the late 1990s to the late 2000s. Some diagonal patterns are apparent
during the milder H1N1 era that spans between those two periods but only at
ages below 60. Of note are the cohorts born around the 1968 pandemic (dashed
diagonal lines in Figs. 4 and 5), which were presumably exposed early in life to
.
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the 1968 H3N2 influenza pandemic virus and which thereafter experienced lower
mortality relative to neighboring cohorts (see the light tone “valley” between
1996 and 2006, marked by a dashed diagonal line in Figs. 4 and 5). Figure 4
also suggests the presence of a slight drop in mortality for the 1947 cohort (the
tone is generally lighter for this cohort relative to its neighbors, as is clearly the
case between 1993 and 1997) and of other “punctual” cohort effects, but further
analyses are needed in order to provide firmer support for these observations.
The results of our APC analyses presented next help provide such support.
Fig. 5 Three-dimensional perspective of the influenza mortality estimated by the Serfling model applied to
P&I mortality data. This section frames ages 20–60 and period 1990–2008, covered by the dashed square in
Fig. 4, panel a. The dashed diagonal line locates the 1968 birth cohort. Arrows d and e mark severe H3N2
epidemics (see also Fig. 4).
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Linear APC Trends
Because age-specific effects are regular over time, we focus on period-specific and
cohort-specific influences on mortality change. According to our APC detrended
model, the long-term slope of mortality change is –0.02024 (p < .001). In other words,
adjusting for age effects, influenza mortality risk significantly decreased by an average
of 2.02 % per year between 1959 and 2016. Figure 6 and Table S5 (online appendix)
present APC estimates of influenza mortality derived from two scenarios in which this
linear trend is completely attributed either to period influences (APCd, dotted line) or to
cohort influences (ACPd, solid line), as well as from the IE model (dashed line).
As expected, the period effect estimates (Fig. 6, left panel; Table S5, upper part)
reveal important fluctuations of mortality that closely follow the major antigenic drifts
and shifts that took place in the last few decades. Independent of the model’s param-
etrization, important peaks are immediately visible for the 1968 H3N2 pandemic as
well as for the 2003–2004 and 2014–2015 severe H3N2 epidemic seasons. Appreciable
dips are also apparent for the 1981–1982, 1993–1994, and 2005–2006 epidemic
seasons, during which the dominant subtype was the less virulent H1N1 seasonal virus.
Regarding the long-term linear cohort effects (Fig. 6, right panel; Table S5, lower
part), the IE estimates are very similar to those from the ACPd model, suggesting that
broadly defined cohort influences mainly account for improvements over time in
influenza mortality. The ACPd and the IE estimates both depict a slight increase of
mortality throughout cohorts born from 1860 to the late 1890s, followed by a sharp
decline from one cohort to the next, continuing to the last decades of the twentieth
century. This trend differs markedly from the flatter trend drawn from the APCd
estimates, which instead suggests a sizable increase in mortality across cohorts born
in the second half of the nineteenth century, followed by a monotonic reduction for
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Fig. 6 Period and cohort relative (to average) risks of influenza-related mortality derived from the Serfling
model, ages 5–100, 1959–2016. The bold gray vertical lines highlight birth cohorts where statistically
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cohorts born from around 1900 to the 1930s, and a leveling off thereafter. Note that a
method that attributes all the linear trends of mortality to period changes, such as the
APCd method, naturally yields a cohort trend that neither increases nor decreases over
the period of observation.
Despite substantial differences in the aforementioned scenarios and uncertainties
regarding the true trends, some attributes of the cohort effects are common to the three
sets of APC estimates: all suggest a decline in the cohort mortality trend for individuals
born between 1900 and 1930 and between 1957 and 1968, as well as an increasing
trend for years of birth ranging from 1947 to the mid-1950s, and from 1968 to the end
of the 1970s. Afterward, the cohort trend might have been either decreasing or leveling
off.
Changes in Trends
Based on visual inspection of Fig. 6, we first identified several ostensible turning points
in the cohort effects trend and then investigated these further using the linear contrasts
approach. Table 2 lists the six turning points where we identified that changes in the
direction of the cohort trend were statistically significant, along with the magnitude of
these changes; the turning points are also marked by bold gray vertical lines in the right
panel of Fig. 6. Two disjoint blocks composed of 8 to 16 single-year cohorts (i.e., 4 to 8
two-year cohorts) were defined for each breakpoint. We performed the two alternative
contrast approaches, denoted a and b. For five breakpoints out of six, the changes in
slope were significant (p < .01 or p < .05), regardless of the estimated contrast (for one
breakpoint, p < .10). For simplicity, we focus here on contrast a.
The first contrast in Table 2 indicates a change in slopes of magnitude –0.528 (p <
.001) between two blocks composed of 8 two-year cohorts each, indicating a difference
of –0.033 in the slope by single-year cohort. This contrast mortality flanks the cohorts
born at the turn of the twentieth century (~1896–1901), with the first block including
cohorts born from 1882–1883 to 1896–1897, and the second block including those
born from 1900–1901 to 1914–1915. The negative contrast indicates a reduction in the
Table 2 Contrasts for comparing the linear trends between two disjoint blocks of 2-year birth cohorts
Number
Cohorts Where
Changes in
Slope Occur Block 1 Block 2 Contrast a SE Contrast b SE
1 ~1896–1901 1882–1897 1900–1915 –0.528*** 0.085 –5.584*** 0.774
2 ~1928–1929 1914–1929 1928–1943 0.214* 0.093 1.802* 0.774
3 ~1946–1947 1940–1947 1946–1953 0.246** 0.095 0.772** 0.295
4 ~1956–1957 1946–1957 1956–1967 –0.430*** 0.100 –0.982*** 0.221
5 ~1968–1969 1960–1969 1968–1977 0.393* 0.156 0.839* 0.337
6 ~1976–1981 1968–1977 1980–1989 –0.335* 0.155 –0.585† 0.354
Notes: Contrast a is defined as the difference between the slopes formed by the straight lines connecting the
first and the last pair of consecutive birth cohorts within each block. Contrast b is defined as the sum of
differences of all slopes formed by any pair of cohorts taken in each block.
†p < .10; *p < .05; **p < .01; ***p < .001
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slope of the trend of the second block relative to the slope of the first block (see how the
curve depicting the cohort effects is concave down in Fig. 6 for the cohorts born at the
turn of the twentieth century, regardless of the APC method used). It is worth noting
that the crisp peak in Fig. 6 for the cohort 1900–1901 (i.e., a punctual peak flanked by a
trough at each side) is the result of systematic misreporting of age (and year of birth) in
the death certificates of people born around 1900. Such age heaping, also visible in the
form of a diagonal trace in Fig. 4 for the 1900 cohort, is described for influenza
mortality during the 1918 influenza pandemic in Ontario in Hallman (2015).
The second contrast indicates an increase of 0.214 (0.013 per year, p < .05) in the
slope of the cohort trend around 1926–1927. A third contrast indicates a significant
upward change of 0.246 (0.031 per year, p < .01) in the slope of the trend after the
1946–1947 cohort. The fourth contrast suggests a 0.430 downward change in slope
(0.036 per year, p < .001) after the 1956–1957 birth cohorts. A fifth contrast reveals a
significant 0.393 increase in slope (0.039 per year, p < .05) after 1968–1969, and a
sixth identifies a decrease of 0.335 (0.034 per year, p < .05) in the slope after 1976–
1981. The changes in slopes for more recent cohorts were not statistically significant
(the small numbers of death make the estimates uncertain). To test the sensitivity of the
contrast estimates, we reran the model using three-year instead of two-year cohorts. The
results were highly consistent with those presented in Table 2 (see Table S3 in the
online appendix).
Discussion
This study identifies several factors modulating influenza mortality in the U.S. popu-
lation between 1959 and 2016. Consistent with previous analyses (Reichert et al. 2004;
Simonsen et al. 1997; Thompson et al. 2010), the particular IAV subtype circulating
during a given season is an important determinant of all-age mortality during that
season, with H2N2 being the most lethal subtype, followed by H3N2, H1N1, and
pH1N1 (Fig. 3 and Table 1). Over time, the succession and alternation in virus subtypes
from one season to the next leaves clear one-year vertical bars on the Lexis configu-
ration that are genuine period effects affecting all age groups simultaneously (vertical
arrows in Figs. 4 and 5).
Yet, year-to-year changes in virulence and virus subtype also prime successive
cohorts to alternative strains which, through lingering effects on later-life mortality,
may leave specific diagonal traces on the Lexis configuration typical of a cohort effect.
Our analyses suggest up to three, perhaps four, such “imprinted cohort” effects,
centered on the 1947, 1957, 1968, and ~1978–1980 cohorts. The other two significant
contrasts identified for the ~1896–1901 and ~1928 cohorts could also be interpreted as
imprinted cohort effects, but we believe that they point to longer-term changes in
mortality at older ages, in line with the cohort morbidity phenotype. We discuss first the
imprinted cohort effects.
The most obvious one concerns the cohorts born at the time of the 1968–1969
“Hong Kong flu” pandemic. Mortality in these cohorts was lower relative to neigh-
boring cohorts, as observed in Figs. 4, 5, and 6, and confirmed by a statistically
significant change in slope documented in Table 2. We propose that individuals from
the 1968–1969 birth cohorts developed a robust immune response to the H3N2
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pandemic virus circulating around the time of their birth. They then benefited from
having been primed to that variant when exposed again to subsequent (and numerous)
epidemics dominated by the same H3N2 subtype, which has proved to be more lethal
than the co-circulating H1N1 variant. However, APC analysis conducted on all-cause
mortality and other causes of death (cardiovascular and respiratory) also produced a dip
in mortality for cohorts born at the end of the baby boom (Table S4, online appendix).
This suggests that the 1968 cohort could also have benefitted from a reduction in
influenza mortality unrelated to its early-life antigenic imprinting. Although we cannot
fully discard this possibility, we note that the significant contrast identified for influenza
mortality is precisely centered on the 1968 cohort in Table S4, whereas the signal for
all-cause, cardiovascular, and respiratory mortality is dispersed among cohorts born up
to six years before or after 1968.
If the 1968–1969 cohorts benefited from lower mortality relative to neighboring
cohorts, the opposite is true for those born around 1978–1980. The increment of
influenza risk of death among the cohorts born from 1969 to 1976 likely results
from the gradual decrease in the proportion of cohort members primed to the H3N2
subtype. Indeed, with the B subtype, the H1N1—reintroduced into the circulation in
early 1978—largely dominated the 1976–1977, 1979–1980, and 1981–1982 flu
seasons, and the relative gain in protection that the H1N1-primed cohorts born those
years might have had during subsequent outbreaks caused by the H1N1 subtype
was more than offset by lack of protection during the more deadly H3N2 outbreaks.
Accordingly, the risk could have decreased for cohorts born after 1980 because a
higher proportion of individuals among these cohorts were primed to the co-
circulating H3N2.
The picture is less clear for the cohorts born around 1957, who were primed to
the H2N2 virus that appeared that year, during the so-called Asian flu pandemic.
The drop in mortality following that cohort in Fig. 6 and the significant contrasts
shown in Table 2 suggest that these cohorts benefitted from cross-protective
immunity during the H3N2 seasons through sharing the neuraminidase component
N2. Alternatively, the immune systems of the members of this cohorts might have
been “refocused” on the H3N2 subtype upon early-life exposure in 1968, adjusting
its antigenic signature to this subtype in time, at a relatively young age (Gagnon
et al. 2015). Again, the baby boom could have had a role in this context: the 1957
cohort was among the largest of the era, with potential for increased mortality, as
described in Easterlin (1987). However, although we find significant contrasts for
all-cause and respiratory disease mortality for the 1957 cohort, this signal appeared
much more dispersed around that cohort than for influenza mortality (Table S4).
A decade before the Asian flu pandemic, during the 1946–1947 season, a vaccine
that was previously effective against the circulating H1N1 virus during the prior
seasons totally failed to provide protection because of what turned out to be an
important intrasubtypic antigenic drift, akin to a pseudo-pandemic (Kilbourne
2006). Yet, there is no simple immunologic explanation as to why the curve is
concave up in Fig. 6 for the cohorts born at that time, quite the contrary given that a
deep imprint from H1N1 should instead have increased the risks of mortality in
subsequent decades from the H3N2 subtype, as explained above for the 1978–1980
cohorts. Perhaps priming to H1N1 in 1947 was still protective relative to priming to
H2N2 in 1957, which was associated with an increase in mortality during the 2009
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H1N1 pandemic and the 2013–2014 resurgent outbreak (Gagnon et al. 2018a).
However, other mechanisms unrelated to imprinting might have been at play, such
as selection. The year 1947 is notorious not only for a major antigenic drift.
Demographers have also noted a record-breaking number of marriage licenses
issued in May and June 1946 (Whelpton et al. 1947), the first spring season to
follow the conclusion of WWII, and therefore a sudden surge of fertility in 1947.
Given that the healthiest couples had their first babies within a year following their
marriage, the 1947 cohort could have been graced with greater than usual health via
synchronization of the fertility of the healthiest parents. Such a “selection-by-
synchronization” phenomenon was proposed earlier to explain a surge in the
frequency of twin births at the end of WWI in France (Pison et al. 2004).
Of note is the lack of a cohort effect for those born during the 1918 Spanish flu
pandemic, which left no specific diagonal trace in the Lexis configuration and produced
no significant second-order cohort effects in the contrast analysis. It is possible that
selection processes for this cohort offset the lingering effects of early-life exposure to
the H1N1 virus that caused the 1918 pandemic. However, its antigenic signature was
apparently not fully erased. During the 1968 influenza pandemic, death rate ratios
(relative to previous influenza seasons) peaked for the cohorts born around 1918
(Gagnon et al. 2015), while these same cohorts appeared protected during the 2009
flu pandemic (Gagnon et al. 2018a; Jacobs et al. 2012; Nguyen and Noymer 2013).
We hypothesize that the extent to which the lingering effects from early-life im-
printing is recognizable depends on the life stage at which mortality is observed. In this
study, we observe the cohorts primed to the 1918 virus mostly during seasonal
outbreaks, at advanced ages, when influenza deaths would usually no longer directly
result from the virus itself, but rather from comorbid conditions and poor health (Plans-
Rubió 2007; Reichert et al. 2004; Simonsen et al. 2005), and thus, under the regime of
the cohort morbidity phenotype. Accordingly, these differences by age are reflected in
the parameterization of the surveillance model in this study. As shown in Table S1 in
the online appendix, for ages above 65, the model using a measure of ILI with no
subtype distinction provided the best fit, whereas for ages 25 to 65, the inclusion of the
information related to the virus subtype circulation significantly improved model fit.
This brings us to the contrasts identified for the cohorts born around 1900 and 1928
(see Table 2). The two years are often considered as years of significant antigenic drifts
(Beveridge 1991; Collins 1931; Patterson 1986). Although the status of the first is
debated (Hill et al. 2017), there is potential for long-term imprinted cohort effects for
individuals born during those two years, as described in this study for more recent
cohorts. However, we believe that the contrasts for these cohorts born in the first half of
the twentieth century (observed at older ages in this study) are rather mainly indicative
of broader transition processes.
Researchers have extensively documented a context of deprived sanitary conditions
in Northern America during the late nineteenth century due to the rapid growth of
cities, reflected in high infant and child mortality (Burian et al. 2000; Haines 2000;
Olson and Thornton 2011). Despite important discoveries in bacteriology in the
nineteenth century, germ theory did not begin to guide public policies until the turn
of the twentieth century. As Preston and Haines (1991:22) argued, “There is probably
no area of public health where a majority of the progress between 1850 and 1950
occurred by 1900.” However, between 1900 and 1930, the United States experienced
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the most rapid decline in mortality rates in documented history as a result of sharp
reductions in infant mortality from infectious diseases (Cutler and Miller 2005). This is
consistent with the downward trend in cohort effects between these dates: progressively
lower levels of disease load early in life translated into lower and lower levels of
influenza mortality later in life.
Congruently, a distinctive second-order linear contrast around 1900 clearly marks
the beginning of this trend (Table 2). This contrast remained highly significant when
moving the rupture point forward or backward by up to six years (Table S4 shows
constant contrasts up to four years forward or backward), suggesting that it is not
associated to one specific antigenic drift year but to a smoother and longer-term change.
Because the contrast identified about 30 years later is not uniquely centered on the 1928
cohort, it could signal the end of the sharp decline in influenza mortality that began
with the cohorts born at the turn of the twentieth century. Had this contrast mainly
resulted from the 1928 antigenic event, the changes in the slope would also have
appeared more abrupt, more statistically significant, and concentrated on a single year,
as is the case for the subsequent contrasts. Admittedly, it is not possible with the data at
hand to provide firmer evidence regarding the nature of the contrasts identified. It is
also possible that both antigenic imprinting and cohort morbidity phenotype scenarios
are at play in the earlier cohorts of this study.
Our study has several limitations. We discuss three. First, Surveillance-Serfling
models did not include information about other viruses that could be correlated with
influenza seasonality, such as respiratory syncytial virus. Consequently, our estimations
of influenza mortality could be slightly overestimated. Nonetheless, this potential bias
would be mostly concentrated in children under age 5 (Simonsen et al. 2011), which
were excluded from the APC analysis. In addition, infections with that virus are
unlikely to explain mortality trends that coincide with the circulation of specific strains
of influenza virus in a given season.
Second, mortality data used here are useful for identifying age-related trends but are
limited concerning other concomitant influences affecting disease burden and mortality
risks, such as medical comorbidity, propensity for care-seeking, laboratory testing of
viral strains, or even infection rates, which may break down differently by population
subgroups. Our choice to focus on P&I deaths as a basis to estimate the number of
influenza deaths most likely led to an underestimation of this number, especially at
older ages (because of comorbidities). This means that the old-young difference is
probably biased. Had we used a broader category—such as “cardiorespiratory”—our
model would have proportionally captured more deaths from the exacerbation of
comorbidities at older than at younger ages. Other important factors could affect
mortality outcomes, notably race or sex. Haines noted, for instance, that African
Americans were protected to some extent by their more rural residence in the first half
of the twentieth century, although their mortality remained higher than that of other
Americans (Haines 2000, 2001). It is thus possible that the African Americans who
were born during those years and who survived to the onset of this study in 1959 had a
shallower imprint to specific influenza strains than the general population because of
lower incidence of influenza in early life, with potentially less clear antigenic imprint-
ing effects in these groups. Unfortunately, because of sample size issues, we could not
explore such a possibility in the context of this study. Regarding sex differences, men
are often said to declare more (and complain more from) flu symptoms than women,
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which is popularly encapsulated in the expression “man flu,” perhaps erroneously (Sue
2017). Relative to women, they also appear to be less responsive to influenza vacci-
nation and to be in general more susceptible to complications and death to many acute
respiratory diseases, including influenza (Engler et al. 2008; Furman et al. 2014;
Giefing-Kröll et al. 2015). However, our analyses could not reveal fundamental sex-
based differences with respect to APC patterns of influenza mortality (not shown here).
Third, and perhaps most importantly, the use of first-order APC statistical analysis
has been criticized as unreliable because of the irresolvable issue of full dependency of
the three age, period, and cohort components, which are sensitive to restrictions
arbitrarily imposed (Luo 2013; Luo et al. 2016; O’Brien 2013). Yet, although perfect
collinearity will never be overcome, we believe it is still possible to gain useful
knowledge about cohort trends, especially if several methods are used and if the
analyses are supported and informed by external evidence from history and the social
sciences in general (Luo 2013). For instance, based on Fig. 6, it is unclear whether
mortality increased in cohorts born from 1850 to 1900 or whether it remained relatively
stable. But the same figure shows that three models with widely different sets of
constraints concur to show declining mortality in cohorts born from 1900 to 1930.
This pattern can also be seen in the Lexis surfaces of Figs. 4, and taking into
consideration the historical sketch above, we feel it would be difficult to argue that
period-based rather than cohort-based factors explain this trend. That said, results for
long-term linear trends should always be seen as indicative or exploratory, not as
confirmatory. For recent cohorts, it is no surprise that uncertainties persist about cohort
versus period long-term trends on mortality; these cohorts were observed for only a
short time at relatively young ages, when mortality risks are relatively low.
Conclusion
The findings reported in this study have several key implications. On the one hand, they
suggest that the mechanisms proposed by the antigenic imprinting and the cohort
morbidity phenotype hypotheses are not necessarily mutually exclusive as engines of
influenza mortality variation; these two mechanisms even seem to act simultaneously,
triggering different mortality changes at distinct levels or scales. Yet, the irregular and
sudden changes in influenza mortality at young ages are largely caused by the
interactions between the population’s signature of antigenic imprinting and the charac-
teristics of the virus encountered in adulthood. The progressive decline in influenza
mortality observed in cohorts born between 1900 and 1930 (and for virtually all cohorts
born after 1900 if we accept the IE results), on the other hand, would result from
continuous improvements of early-life conditions (better hygiene, lower disease load in
infancy, and so on), which manifest themselves at older ages.
We suggest that the contrasting mortality patterns reflect a difference in the pathways
that lead from influenza infection to death at different ages and that this difference has
major health policy implications. Interventions for younger patients should be focused
on mitigating the immune response when this response is potentially harmful (e.g.,
during pandemics). On the other hand, in the case of the elderly, indirect pathways
involving comorbid conditions should be targeted as priorities. It is also important that
vaccination campaigns cease to identify susceptible groups of individuals based almost
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exclusively on their age group, and instead define susceptibility from a combination of
APC influences. The yearly defined cohort effects and contrasts are further evidence
that surveillance and mortality data on influenza should be made available by single
years of age to all stakeholders, as Gagnon et al. (2018b) argued. Knowing the strain to
which a cohort has been primed and how “deep” this antigenic signature is would help
to improve the efficiency of immunization campaigns and to inform medical profes-
sionals about priorities based on the age or the generation of patients.
The finding that cohort-specific influences may account for important changes in
influenza mortality at older ages also tempers the common assumption that reductions
in mortality from infectious diseases stemmed exclusively from period-based improve-
ments in environmental and technological factors such as sanitation, hygienic practices,
and medical technology. We argue that a considerable part of improvements, at least for
the cohorts born between 1900 and 1930, was accomplished on a cohort basis. In this
context, the general increase in overall mortality from influenza, which is expected in
the coming years because of population aging (Simonsen et al. 2011), might be
tempered by long-term beneficial effects of earlier improvements in early-life condi-
tions. Therefore, our results highlight the importance of these conditions not only for
the reduction of chronic and degenerative mortality but also for the enhancement of
survival from infectious diseases at old ages. It would be interesting to perform similar
analyses on other infectious diseases to assess the generalizability of the scenarios
proposed here.
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